Stocks and Investing
Stocks and Investing
Wed, December 4, 2013
[ 12:00 AM ] - WOPRAI
Tue, December 3, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, December 2, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, November 29, 2013
Wed, November 27, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 26, 2013
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Christopher Raymond Initiated (BIIB) at Buy on, Nov 26th, 2013
Christopher Raymond of Piper Sandler, Initiated "Biogen Inc." (BIIB) at Buy on, Nov 26th, 2013.
Christopher has made no other calls on BIIB in the last 4 months.
There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Christopher
- Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $340 on, Friday, November 22nd, 2013
- Evan Seigerman of "Credit Suisse" Maintained at Buy and Held Target at $290 on, Friday, November 22nd, 2013